Pharmaceuticals, Biotechnology and Life Sciences
Launch underway for FDA-approved PALFORZIA™, the first treatment for peanut allergy In-licensing of AIMab7195 monoclonal antibody as potential adjunctive treatment…
BLA for ROLONTIS® (eflapegrastim) accepted for FDA review – PDUFA date on October 24, 2020 Data from poziotinib Cohort 1…
− Appoints Dr. Olivier Brandicourt, Former CEO of Sanofi and Global Pharmaceutical Industry Leader − − Announces Retirement of Dr.…
Medidata to apply proprietary artificial intelligence tools to aid the fight against ALS New initiative is part of Medidata’s ongoing…
DUBLIN–(BUSINESS WIRE)–The “Nanoemulsion Market by Type and Application: Global Opportunity Analysis and Industry Forecast 2019-2026” report has been added to…
The 2020 Entrepreneur & Investor Life Science Summit, sponsored by Simpson Thacher, is the premier conference for engaging life sciences…
LAVAL, Quebec–(BUSINESS WIRE)–#Altasciences—Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from…
LONDON–(BUSINESS WIRE)–#GlobalNeuroscienceAntibodiesandAssaysMarket–The global neuroscience antibodies and assays market is poised to grow by USD 1.36 billion during 2020-2024, progressing at…
DUBLIN–(BUSINESS WIRE)–The “Global Marine Biotechnology Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. Global Marine Biotechnology Market 2020-2024 The…
Submission supported by pivotal CAPTAIN study demonstrating statistically significant improvement in lung function compared with the ICS/LABA, Relvar/Breo Ellipta At…